Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedMar 13, 2026
DataAggregated Company Financials
Companies117
  • 7D-8.4%
  • 3M-11.6%
  • 1Y-12.0%
  • YTD-12.0%

Over the last 7 days, the Personal Products industry has dropped 8.4%, driven by a pullback from Estée Lauder Companies of 12%. In contrast, Yatsen Holding has gained 6.6%. Overall the industry is down 12% in 12 months. Looking forward, earnings are forecast to grow by 31% annually.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 13 Mar 2026US$84.2bUS$48.2bUS$794.3m22.3x105.9x1.7x
Sun, 08 Feb 2026US$90.1bUS$48.1bUS$994.1m21.4x90.6x1.9x
Tue, 06 Jan 2026US$89.7bUS$47.6bUS$350.3m21.2x256.2x1.9x
Thu, 04 Dec 2025US$87.2bUS$47.6bUS$351.0m23.1x248.4x1.8x
Sat, 01 Nov 2025US$85.4bUS$47.8bUS$493.6m21x173x1.8x
Mon, 29 Sep 2025US$89.1bUS$47.6bUS$307.5m21.2x289.8x1.9x
Wed, 27 Aug 2025US$99.4bUS$47.6bUS$303.7m22.2x327.3x2.1x
Fri, 25 Jul 2025US$103.4bUS$48.1bUS$108.7m21.4x951.9x2.2x
Sun, 22 Jun 2025US$95.6bUS$48.0bUS$108.0m17.2x885.1x2x
Tue, 20 May 2025US$94.9bUS$48.0bUS$114.3m18.1x830.4x2x
Thu, 17 Apr 2025US$83.4bUS$48.7bUS$556.7m22.3x149.8x1.7x
Sat, 15 Mar 2025US$90.3bUS$48.6bUS$350.0m30.2x257.9x1.9x
Mon, 10 Feb 2025US$87.1bUS$49.1bUS$531.8m25.3x163.8x1.8x
Wed, 08 Jan 2025US$96.1bUS$49.3bUS$1.5b25.4x65.1x1.9x
Fri, 06 Dec 2024US$105.1bUS$49.3bUS$1.5b29.1x71.3x2.1x
Sun, 03 Nov 2024US$96.7bUS$49.3bUS$1.4b24.9x67.3x2x
Tue, 01 Oct 2024US$112.5bUS$49.5bUS$1.6b26.3x68.9x2.3x
Thu, 29 Aug 2024US$109.8bUS$49.5bUS$1.6b22.2x68.1x2.2x
Sat, 27 Jul 2024US$106.8bUS$48.9bUS$2.4b22.8x44.3x2.2x
Mon, 24 Jun 2024US$113.1bUS$49.0bUS$2.4b22.9x46.7x2.3x
Wed, 22 May 2024US$119.4bUS$48.8bUS$2.5b21.1x48.7x2.4x
Fri, 19 Apr 2024US$125.2bUS$48.8bUS$2.5b25.6x49.4x2.6x
Sun, 17 Mar 2024US$133.2bUS$48.7bUS$2.5b25.1x53.1x2.7x
Tue, 13 Feb 2024US$129.6bUS$49.2bUS$2.6b25.9x50.5x2.6x
Thu, 11 Jan 2024US$128.2bUS$49.9bUS$2.6b27.1x48.7x2.6x
Sat, 09 Dec 2023US$122.1bUS$49.9bUS$2.6b26.5x46.9x2.4x
Mon, 06 Nov 2023US$105.5bUS$49.7bUS$2.8b23.6x37.1x2.1x
Wed, 04 Oct 2023US$121.8bUS$50.0bUS$3.3b23.4x37x2.4x
Fri, 01 Sep 2023US$136.9bUS$50.0bUS$3.3b20.3x41.8x2.7x
Sun, 30 Jul 2023US$144.3bUS$49.8bUS$3.1b25.3x47.1x2.9x
Tue, 27 Jun 2023US$152.3bUS$49.3bUS$3.1b22.9x48.6x3.1x
Thu, 25 May 2023US$148.2bUS$49.0bUS$3.3b22.5x44.8x3x
Sat, 22 Apr 2023US$126.2bUS$34.5bUS$1.7b18.1x75.3x3.7x
Mon, 20 Mar 2023US$115.0bUS$34.8bUS$1.5b18x77.7x3.3x
Price to Earnings Ratio

77.7x


Total Market Cap: US$115.0bTotal Earnings: US$1.5bTotal Revenue: US$34.8bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 167.1x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 106x which is lower than its 3-year average PE of 167x.
  • The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 19% per year over the last three years.
  • Meanwhile revenues for these companies have grown 11% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market-2.29%
Consumer Staples-0.79%
Personal Products-8.35%
Personal Products-8.35%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
YSG Yatsen HoldingUS$4.026.6%
+US$23.5m		-18.0%PS0.6x
LFVN LifeVantageUS$5.159.6%
+US$5.8m		-69.5%PE8.4x
BHST BioHarvest SciencesUS$4.170.5%
+US$453.1k		-19.7%PS2.9x
NHTC Natural Health TrendsUS$3.121.6%
+US$428.9k		-38.6%PS0.7x
PAVS Paranovus Entertainment TechnologyUS$1.5523.0%
+US$371.1k		-98.9%PS0.2x

Latest News

YSG
US$4.02
Yatsen Holding
7D
6.6%
1Y
-18.0%
LFVN
US$5.15
LifeVantage
7D
9.6%
1Y
-69.5%
IPAR
US$90.82
Interparfums
7D
-5.3%
1Y
-27.2%

IPAR: Asset Light Model Will Benefit From Expanded Long Term Fragrance Licenses

Analysts have raised their fair value estimate for Interparfums from $107.40 to $111.20, citing updated assumptions around revenue growth, profit margins, the discount rate, and a revised future P/E that align with recent Street research coverage. Analyst Commentary Bullish Takeaways Bullish analysts view the higher fair value estimate of $111.20 as more in line with updated assumptions on revenue growth and margins, which they see as better aligned with recent Street work on the name.
KVUE
US$17.39
Kenvue
7D
-4.7%
1Y
-25.0%

KVUE: Future Returns Will Balance Legal Risks And Kimberly Clark Deal Execution

Analysts have nudged their fair value estimate for Kenvue to $19.83 from $19.67, reflecting recent price target increases into the $18 to $20 range after what they describe as a better than feared Q4 with broad-based segment growth. Analyst Commentary Recent Street research on Kenvue highlights a mix of cautious optimism and lingering concerns, with several firms lifting price targets into the high teens after reviewing Q4 results and updated models.
HLF
US$15.22
Herbalife
7D
-5.9%
1Y
88.6%

HLF: 2026 Turnaround Hopes Will Confront Persistent Competitive And Fundamental Risks

The analyst price target for Herbalife has been raised by $1 to $9. Analysts point to largely in line Q4 results, new 2026 guidance, and a mix of Buy, Neutral, and Underperform views that reflect both perceived momentum and ongoing concerns around competition, fundamentals, and valuation.
COTY
US$2.22
Coty
7D
-7.5%
1Y
-59.1%

COTY: Gucci License Exit And New CEO Will Test Fragrance Reliance

The analyst price target on Coty has been reduced by about $0.50, as analysts factor in lower fair value estimates and more moderate revenue growth and margin assumptions, even as they apply a slightly lower discount rate and a modestly higher future P/E multiple. Analyst Commentary Recent Street research on Coty has leaned cautious, with several bearish analysts trimming their price targets in relatively quick succession.
BHST
US$4.17
BioHarvest Sciences
7D
0.5%
1Y
-19.7%

CDMO Pipeline And Capacity Expansion Will Face Setbacks Yet Ultimately Support Future Earnings

Catalysts About BioHarvest Sciences BioHarvest Sciences develops and commercializes plant derived compounds using its patented Botanical Synthesis platform, serving pharmaceuticals, nutraceuticals, cosmetics and nutrition. What are the underlying business or industry changes driving this perspective?
OLPX
US$1.24
Olaplex Holdings
7D
-15.4%
1Y
-7.5%

OLPX: Henkel Takeover Talks And Refined Earnings Profile Will Reprice Shares

Analysts have lifted their price target on Olaplex Holdings to $3.59, citing updated assumptions around a slightly lower discount rate, more measured revenue growth, a modestly higher profit margin profile, and a recalibrated future P/E multiple informed by recent research from Barclays and Jefferies. Analyst Commentary Bullish analysts are framing the latest price target move to US$3.59 as part of a more constructive view on Olaplex Holdings, built around refined assumptions on discount rates, revenue pacing, profit margins, and future valuation multiples informed by recent research.
EL
US$84.29
Estée Lauder Companies
7D
-12.1%
1Y
30.0%
ELF
US$72.58
e.l.f. Beauty
7D
-12.1%
1Y
15.3%

ELF: Fair Outlook Weighs Weekly Sales Strength Against Margin And P E Risks

Analysts have made only a modest tweak to their blended price target for e.l.f. Beauty, with mixed $10 and $7 cuts alongside $4 and $6 raises and fresh bullish coverage, reflecting updated views on its revenue growth, margins, and future P/E assumptions. Analyst Commentary Recent research on e.l.f. Beauty shows a split in sentiment, with some firms lifting price targets or starting coverage on a bullish footing, while others are trimming their expectations.
EPC
US$18.63
Edgewell Personal Care
7D
-11.7%
1Y
-38.3%

EPC: Share Repurchases And 2026 Earnings Reset Will Guide Balanced Return Potential

Analysts kept their $21.00 price target for Edgewell Personal Care unchanged, citing small refinements to discount rate, long run revenue trends and profit margin assumptions, along with a slightly lower future P/E multiple as reasons for maintaining their overall valuation view. What's in the News Completion of a long running share repurchase program, with 9,773,306 shares bought back for $356.96 million under the buyback announced on February 8, 2018 (Key Developments) Update that from October 1, 2025 to November 13, 2025, the company did not repurchase additional shares under the 2018 buyback program, with 0 shares and $0 million recorded for that period (Key Developments) Launch of a new share repurchase authorization on November 13, 2025, with no shares repurchased and $0 million deployed from November 13, 2025 to December 31, 2025 under this newer program (Key Developments) Revision of full fiscal year 2026 earnings guidance, reflecting removal of the Feminine Care business and presenting outlook on a continuing operations basis, with prior periods recast for comparability (Key Developments) Updated 2026 outlook assumptions, including expected reported net sales change in a range of approximately 0.5% to 3.5%, organic net sales in a range of a 1.0% decline to a 2% increase, and GAAP EPS in a range of $0.55 to $0.95 including restructuring, Sun Care reformulation and other costs (Key Developments) Valuation Changes Fair Value: The $21.00 fair value estimate is unchanged, so the overall valuation anchor remains the same.
NHTC
US$3.12
Natural Health Trends
7D
1.6%
1Y
-38.6%
ELAB
US$4.40
PMGC Holdings
7D
3.9%
1Y
-98.7%
UG
US$6.55
United-Guardian
7D
0.8%
1Y
-33.6%

What United-Guardian, Inc.'s (NASDAQ:UG) 25% Share Price Gain Is Not Telling You

Feb 03
What United-Guardian, Inc.'s (NASDAQ:UG) 25% Share Price Gain Is Not Telling You
PAVS
US$1.55
Paranovus Entertainment Technology
7D
23.0%
1Y
-98.9%

Improved Revenues Required Before Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) Stock's 30% Jump Looks Justified

Jan 23
Improved Revenues Required Before Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) Stock's 30% Jump Looks Justified